Cardiff Oncology is entering a pivotal stage with a strong cash runway and compelling early data in first-line RAS-mutant ...

A lunch at the Saudi royal court in Riyadh gave President Donald Trump, Saudi leaders and numerous business executives an ...

We recently published a list of Why These 10 Stocks Soared by Double Digits Today. In this article, we are going to take a ...

Beyond the major indices, 10 companies finished the week stronger, booking double-digit gains during the day. In this article ...

The commercial distribution of ANKTIVA commenced in May 2024, and the company believes it has the potential to become a ...

SAN DIEGO (AP) — SAN DIEGO (AP) — ImmunityBio, Inc. (IBRX) on Monday reported a loss of $129.6 million in its first quarter. On a per-share basis, the San Diego-based company said it had a loss of 15 ...

ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced certain operational results following ...

ImmunityBio, Inc.’s IBRX share price has surged by 10.14%, which has investors questioning if this is right time to sell.

We recently published a list of 10 Low Risk High Reward Stocks Set to Triple by 2030. In this article, we are going to take a ...

NewLimit, an anti-aging biotech startup backed by Coinbase CEO Brian Armstrong, raised a $130 million Series B round.

The leading Merkel Cell Carcinoma Companies such as ImmunityBio, OncoSec Medical, Exelixis, 4SC, Kartos Therapeutics, Incyte ...

The Refusal to File letter comes despite the FDA’s prior encouragement to submit a supplemental biologics license application ...